Tekturna HCT (Novartis Pharmaceuticals Corporation)


Welcome to the PulseAid listing for the Tekturna HCT drug offered from Novartis Pharmaceuticals Corporation. This Renin Inhibitor [EPC],Renin Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Novartis Pharmaceuticals Corporation
NON-PROPRIETARY NAME: aliskiren hemifumarate and hydrochlorothiazide
SUBSTANCE NAME: ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Renin Inhibitor [EPC],Renin Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2008-08-01
END MARKETING DATE: 0000-00-00


Tekturna HCT HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTekturna HCT from Novartis Pharmaceuticals Corporation
LABELER NAME: Novartis Pharmaceuticals Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 150; 12.5(mg/1; mg/1)
START MARKETING DATE: 2008-08-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0078-0521_99caa324-90fc-4adc-a417-1fbfc82d3940
PRODUCT NDC: 0078-0521
APPLICATION NUMBER: NDA022107

Other ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Noden Pharma USA, Inc.Tekturna HCT
Novartis Pharmaceuticals CorporationTekturna HCT
Physicians Total Care, Inc.Tekturna HCT